Sublimed-actiTENS

Sources

1– The InApp survey conducted from 03/17 to 04/10/23 among 127 patients using actiTENS for the management of endometriosis pain.

2– The inApp survey conducted from 10/21 to 11/25/21 among 183 patients using actiTENS for the relief of various types of pain

3– https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5319385/

4– https://www.medpagetoday.com/resource-centers/clinical-challenges-knee-osteoarthritis

5– https://www.oarsijournal.com/article/S1063-4584(21)00599-9/fulltext

6– https://www.who.int/news-room/fact-sheets/detail/endometriosis

7– https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10241351/

8– https://www.who.int/news-room/fact-sheets/detail/endometriosis

9– InApp survey conducted from 31/05 to 26/06/23 among 68 patients new users of actiTENS suffering from various pathologies and having previously used another TENS.

The placement of actiTENS on the knee to relieve knee osteoarthritis pain.

actiTENS® has been cleared by the FDA (510(k): K202159) in December 2020. actiTENS® is a medical device subject to contraindications. Please carefully read the actiTENS® manual before use.

Download Our App

Explore an innovative approach to pain relief by downloading the actiTENS app now!

SAS Sublimed 813 959 012 00010 – Réf : SBM1AM021_US – V1 – 2024

© Copyright – All rights reserved.